Highlights in Myelofibrosis Research at ASH 2024: Momelotinib in Anemic Patients
Автор: Blood Cancers Today
Загружено: 2024-12-30
Просмотров: 122
At the 66th American Society of Hematology Annual Meeting & Exposition there met a discussion panel of myelofibrosis experts moderated by Prithviraj Bose, MD, of MD Anderson Cancer Center. The panel included Francesca Palandri, MD, PhD, of Università di Bologna, Andrew Kuykendall, MD, of Moffitt Cancer Center, and Lucia Masarova, MD, of MD Anderson Cancer Center.
The topic for the concluding segment of the discussion was current clinical investigations into momelotinib for anemia in myelofibrosis. Dr. Masarova elaborated on a recent noteworthy study of the agent in patients refractory to ruxolitinib, and Dr. Bose spoke of upcoming research into combination of momelotinib with luspatercept.
----------
Blood Cancers Today is a new publication that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
